Rare diseases
Investigational molecules
Locations
Back to Spain36 clinical trials in Galdakao, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
SpainStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
SpainStudy on Levothyroxine and Sildenafil for Improving Erectile Function in Patients with Subclinical Hypothyroidism and Erectile Dysfunction
SpainLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
SpainStudy on Intravenous Ferric Carboxymaltose for Preoperative Anemia in Patients with Lower Limb Peripheral Artery Disease
SpainStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
SpainStudy Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
SpainStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
SpainStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
SpainStudy of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Treatment
SpainStudy of Alpelisib, Trastuzumab, and Fulvestrant for Patients with PIK3CA Mutated HER2+ Advanced Breast Cancer Previously Treated with Trastuzumab
SpainStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on breast cancer treatments, including trials for HER2-positive and triple-negative variants. Research encompasses innovative therapies for pancreatic adenocarcinoma and colon cancer.
Multiple trials evaluating novel drug combinations and targeted therapies for improved patient outcomes.
Comprehensive research into pulmonary fibrosis and respiratory conditions, with studies examining new treatments for COPD and pulmonary embolism management.
Innovative approaches to improve lung function and patient quality of life.
Investigations into cardiomyopathy prevention and treatment, including trials for acute coronary syndromes and peripheral arterial disease management.
Focus on preventive strategies and improved treatment protocols for heart conditions.
Studies addressing endocrine disorders, including hypothyroidism and its effects. Research on hepatic conditions and smoking cessation therapies.
Diverse therapeutic approaches targeting various medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
